Moderna (MRNA) CEO Stephane Bancel said the group was not changing its forecasts after first-quarter results that beat expectations. The drugmaker remains cautious on its forecasts, and on the lookout for the emergence of new variants. 

(MT Newswires)

Bloomberg videos